Off-The-Shelf Vaccine Elicits Durable Responses in Pancreatic, Colorectal Cancers

Cure Today·Aug 13

This story is reported by Cure Today. Read what other outlets are saying below, then open the original report for full details.

Full coverage

1

Off-the-shelf cancer vaccine elicits strong immune response in patients with pancreatic and colorectal cancer

UCLA Health·Aug 12

2

Nous-209 neoantigen vaccine for cancer prevention in Lynch syndrome carriers: a phase 1b/2 trial

Nature·Jan 16

3

Elicio Therapeutics Reports Robust, Cytolytic mKRAS-Specific T Cell Responses Across Diverse Patient HLA in Ongoing Phase 2 AMPLIFY-7P Trial of ELI-002 7P and New ELI-004 Preclinical Data at SITC

Elicio Therapeutics·Nov 7

4

Vaccine Elicits Immune Responses in Pancreatic Cancer

Cure Today·Sep 19

5

KRAS-Targeted Vaccine Shows Durable Immune Responses, Survival Benefits in Pancreatic Colorectal Cancers

Pharmacy Times – Pharmacy Practice News and Expert Insights·Aug 13

6

The broad spectrum of cancer and immunotherapy: achievements and limitations

Frontiers·Jan 12

7

Off-the-Shelf Cancer Vaccine Shows Promise in Colorectal and Pancreatic Cancer Patients

Managed Healthcare Executive·Aug 22

8

One-size-fits-all pancreatic cancer vaccine showed promise in early trial

NBC News·Aug 11